Patents by Inventor Suzanne Wendelken
Suzanne Wendelken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11596346Abstract: A technology is described for determining an intended movement from neuromuscular signals. An example method (800) includes receiving electromyography (EMG) data corresponding to single-ended channels of an electrode array (810), where EMG signals are detected by electrodes comprising the single-ended channels of the electrode array and the EMG signals are converted to the EMG data. Determining differential channel pairs for the single-ended channels of the electrode array (820) and extracting feature data from the EMG data of the differential channel pairs (830). Thereafter a feature data set is selected from the feature data of the differential channel pairs (840) and the feature data set is input to a decode model configured to correlate the feature data set to an intended movement (850). Decode output is received from the decode model indicating the intended movement (860) and the decode output is provided to a device (870).Type: GrantFiled: August 1, 2017Date of Patent: March 7, 2023Assignee: University of Utah Research FoundationInventors: Suzanne Wendelken, Tyler Davis, David Page, David Kluger, David Warren, Gregory Clark, Christopher Duncan, Jacob Nieveen
-
Patent number: 11331499Abstract: A medical implant device (100) is disclosed that can protect and shield an implant (101) as the implant (101) moves through body tissue. The medical implant device (100) can comprise a main body portion (110) having a payload opening (111) to receive a payload (i.e., an implant). The medical implant device (100) can also comprise a tapered nose portion (120) at a front end (103a) of the medical implant device (100) extending from the main body portion (110) and configured to penetrate body tissue. In addition, the medical implant device (100) can comprise a payload coupling interface (130) configured to couple the implant (101) to the main body portion (110).Type: GrantFiled: July 28, 2017Date of Patent: May 17, 2022Assignee: University of Utah Research FoundationInventors: David Kluger, Gregory Clark, Douglas Hutchinson, David Page, Suzanne Wendelken
-
Publication number: 20220022801Abstract: A technology is described for determining an intended movement from neuromuscular signals. An example method (800) includes receiving electromyography (EMG) data corresponding to single-ended channels of an electrode array (810), where EMG signals are detected by electrodes comprising the single-ended channels of the electrode array and the EMG signals are converted to the EMG data. Determining differential channel pairs for the single-ended channels of the electrode array (820) and extracting feature data from the EMG data of the differential channel pairs (830). Thereafter a feature data set is selected from the feature data of the differential channel pairs (840) and the feature data set is input to a decode model configured to correlate the feature data set to an intended movement (850). Decode output is received from the decode model indicating the intended movement (860) and the decode output is provided to a device (870).Type: ApplicationFiled: August 1, 2017Publication date: January 27, 2022Inventors: Suzanne Wendelken, Tyler Davis, David Page, David Kluger, David Warren, Gregory Clark, Christopher Duncan, Jacob Nieveen
-
Patent number: 11022619Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.Type: GrantFiled: August 6, 2018Date of Patent: June 1, 2021Assignee: University of Utah Research FoundationInventors: Annette Macintyre, Lara Brewer, Suzanne Wendelken, Quinn Tate, Soeren Hoehne
-
Patent number: 10690684Abstract: A system for measuring the blood loss comprises a measuring device that determines the hemoglobin concentration of fluid within a container utilizing a light source and a light detector. The container receives blood and other fluids from a patient during a medical procedure. Light from the light source is passed through the blood and other fluids in the container and is detected by the light detector. Based upon a magnitude of light detected, the hemoglobin concentration of the fluid in the container can be determined. A volume-measuring device determines the volume of blood and fluid in the container. Knowing the hemoglobin concentration and volume of fluid in the container, the volume of patient blood loss in the container can be determined. The blood loss measuring device in combination with infusion systems maintains a real-blood volume status so that proper infusion of blood, crystalloid and/or colloid solutions occurs.Type: GrantFiled: October 11, 2018Date of Patent: June 23, 2020Assignees: Majelco Medical, Inc., University of Utah Research FoundationInventors: Annette Macintyre, Lara Brewer Cates, Suzanne Wendelken, Quinn Tate, Soeren Hoehne, Alfred Akerman, Stephen W. Allison, Matthew B. Scudiere, Michael R. Cates, David L. Beshears, Adan James Akerman
-
Patent number: 10549099Abstract: A technology is described for an electronic peripheral nerve stimulation system. The electronic nerve stimulation system can include a stimulation device and an electrode array. The stimulation device can be operable to generate a high-frequency alternating current. The electrode array can be operable to apply the high-frequency alternating current received from the stimulation device to selected subpopulations of peripheral nerve fibers within a peripheral nerve to block transmission of neural signals along the selected subpopulations of peripheral nerve fibers within the peripheral nerve.Type: GrantFiled: May 1, 2017Date of Patent: February 4, 2020Assignee: University of Utah Research FoundationInventors: David Kluger, Christopher Duncan, David Page, Gregory Clark, Tyler Davis, Suzanne Wendelken
-
Publication number: 20190160289Abstract: A medical implant device (100) is disclosed that can protect and shield an implant (101) as the implant (101) moves through body tissue. The medical implant device (100) can comprise a main body portion (110) having a payload opening (111) to receive a payload (i.e., an implant). The medical implant device (100) can also comprise a tapered nose portion (120) at a front end (103a) of the medical implant device (100) extending from the main body portion (110) and configured to penetrate body tissue. In addition, the medical implant device (100) can comprise a payload coupling interface (130) configured to couple the implant (101) to the main body portion (110).Type: ApplicationFiled: July 28, 2017Publication date: May 30, 2019Inventors: David Kluger, Gregory Clark, Douglas Hutchinson, David Page, Suzanne Wendelken
-
Publication number: 20190041405Abstract: A system for measuring the blood loss comprises a measuring device that determines a hemoglobin concentration of fluid within a container utilizing a light source and a light detector. The container receives blood and other fluids from a patient during a medical procedure. Light from the light source is passed through the blood and other fluids in the container and is detected by the light detector. Based upon a magnitude of light detected, a hemoglobin concentration of the fluid in the container can be determined. A volume-measuring device determines the volume of blood and fluid in the container. Knowing the hemoglobin concentration and volume of fluid in the container, the volume of patient blood loss in the container can be determined. The blood loss measuring device in combination with infusion systems maintains a real-blood volume status so that proper infusion of blood, crystalloid and/or colloid solutions occurs.Type: ApplicationFiled: October 11, 2018Publication date: February 7, 2019Inventors: Annette Macintyre, Lara Brewer, Suzanne Wendelken, Quinn Tate, Soeren Hoehne, Alfred Akerman, Stephen W. Allison, Matthew B. Scudiere, Michael R. Cates, David L. Beshears, Adan James Akerman
-
Publication number: 20180372757Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.Type: ApplicationFiled: August 6, 2018Publication date: December 27, 2018Inventors: Annette Macintyre, Lara Brewer, Suzanne Wendelken, Quinn Tate, Soeren Hoehne
-
Patent number: 10041960Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.Type: GrantFiled: May 9, 2014Date of Patent: August 7, 2018Assignee: University of Utah Research FoundationInventors: Annette MacIntyre, Lara Brewer, Suzanne Wendelken, Quinn Tate, Soeren Hoehne
-
Publication number: 20170312522Abstract: A technology is described for an electronic peripheral nerve stimulation system. The electronic nerve stimulation system can include a stimulation device and an electrode array. The stimulation device can be operable to generate a high-frequency alternating current. The electrode array can be operable to apply the high-frequency alternating current received from the stimulation device to selected subpopulations of peripheral nerve fibers within a peripheral nerve to block transmission of neural signals along the selected subpopulations of peripheral nerve fibers within the peripheral nerve.Type: ApplicationFiled: May 1, 2017Publication date: November 2, 2017Inventors: David Kluger, Christopher Duncan, David Page, Gregory Clark, Tyler Davis, Suzanne Wendelken
-
Publication number: 20160123998Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.Type: ApplicationFiled: May 9, 2014Publication date: May 5, 2016Inventors: Annette MacIntyre, Lara Brewer, Suzanne Wendelken, Quinn Tate, Soeren Hoehne